Overview
Legal name
MOLECULOMICS LIMITED
Region
Wales
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Moleculomics Limited
Home - Moleculomics
Moleculomics Limited is a UK company with status active founded in 2012 based in Wales.
CRN
08340228
Founded
2012
Age
13
Company events
Reference milestones and recent Companies House filing stream events.
3 events
15 Oct
2024
Dissolved Compulsory Strike Off Suspended
DissolutionDISS16(SOAS) | Transaction MzQzOTMwMjU0MGFkaXF6a2N4 | Paper/PDF filed
Published 16 Oct 2024 07:18
17 Sep
2024
Gazette Notice Compulsory
GazetteGAZ1 | Transaction MzQzNTIxMTMxN2FkaXF6a2N4 | Paper/PDF filed
Published 13 Sep 2024 12:01
21 Dec
2012
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2017
Funded years
2017, 2020
Age at first award
4 years
Projects
2020
Feasibility Studies
Lead participant
Generic Rapid Antiviral Screening Platform (GRASP)
1 Jun 2020 to 28 Feb 2021
Awarded
£58,969
Total cost £58,969
The Covid-19 pandemic has exposed gaps in drug discovery capabilities specifically with respect to viral pathogens, such as SARS-CoV-2, but also revealed new opportunities for rapid repurposing of currently prescribed drugs as antiviral agents. The combined power of supercomputing, genomic platforms and machine learning based molecular docking (screening)...
2017
Feasibility Studies
Lead participant
A software tool for patient stratification by genetic variations in drug metabolism
1 Oct 2017 to 30 Jun 2018
Awarded
£69,678
Total cost £99,540
Human drug metabolism and clearance is driven by liver enzymes, most notably the Cytochrome P450s (or CYPs). CYPs are a well characterised superfamily of enzymes, which are of great importance in drug discovery and development. Historically not so well understood is the differential metabolism and adverse events associated with currently prescribed drugs ...
Product types
Feasibility Studies